Dentons is launching a new roundtable series for biotech, pharma and med device leaders—bringing market experts and investors together to share clear perspectives on today’s capital markets, from current challenges to emerging opportunities. Episode 1: State of the Markets Our first session will spotlight the realities of today’s financing and deal-making climate. Hear directly from... View Article

The venture landscape is evolving rapidly, with institutional capital flowing into areas that are shaping both markets and society. From the infrastructure enabling AI to dual-use technologies bridging commercial and national security needs, investors are seeking opportunities that combine innovation with resilience. Join leaders from GV, IQT and Dentons for a virtual conversation that explores... View Article

Halfway through 2025, the venture market remains defined by liquidity concerns and surging interest in AI. Investment power has concentrated among firms with ample dry powder and established track records. Meanwhile, tariffs and geopolitical uncertainty continue to dampen IPO prospects despite a recent surge in new public listings, while a handful of billion-dollar M&A deals... View Article